Tamoxifen Citrate 20 mg/tab 50 pills |

About Tamoxifen Citrate | HilmaBiocare

Tamoxifen Citrate - Hilma Biocare

Tamoxifen citrate is a prescription medication from the Selective Estrogen Receptor Modulator (SERM) class. It has tissue-selective activity (acting as an estrogen antagonist in some tissues and a partial agonist in others). Tamoxifen has established medical use, primarily in hormone receptor–positive breast cancer, under professional supervision.

General Overview

Class: Selective Estrogen Receptor Modulator (SERM)
Structure: Non-steroidal SERM (tamoxifen citrate)
Context of use: Prescription medical use under professional supervision (primarily oncology-related indications)

Potentially Observed Effects
(based on pharmacological action and clinical use)

Estrogen receptor modulation with tissue-dependent effects
Reduction of estrogen receptor signaling in certain tissues where antagonism is clinically relevant
Hormonal axis effects may occur in some individuals (individual variation)
Safety Information

Tamoxifen may be associated with side effects and clinically important risks. Commonly reported adverse effects can include hot flashes, nausea, headache, fatigue, mood changes, and gastrointestinal discomfort. More serious but less common risks include thromboembolic events (e.g., deep vein thrombosis), stroke risk in susceptible individuals, and endometrial changes with longer-term use. Individual responses vary, and use should be guided by a qualified medical professional with appropriate monitoring when indicated.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and use prescription medicines only under qualified medical supervision.